198 related articles for article (PubMed ID: 16375354)
1. Dynamic mechanism of E2020 binding to acetylcholinesterase: a steered molecular dynamics simulation.
Niu C; Xu Y; Xu Y; Luo X; Duan W; Silman I; Sussman JL; Zhu W; Chen K; Shen J; Jiang H
J Phys Chem B; 2005 Dec; 109(49):23730-8. PubMed ID: 16375354
[TBL] [Abstract][Full Text] [Related]
2. How does huperzine A enter and leave the binding gorge of acetylcholinesterase? Steered molecular dynamics simulations.
Xu Y; Shen J; Luo X; Silman I; Sussman JL; Chen K; Jiang H
J Am Chem Soc; 2003 Sep; 125(37):11340-9. PubMed ID: 16220957
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional structure of a complex of E2020 with acetylcholinesterase from Torpedo californica.
Kryger G; Silman I; Sussman JL
J Physiol Paris; 1998; 92(3-4):191-4. PubMed ID: 9789806
[TBL] [Abstract][Full Text] [Related]
4. Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs.
Kryger G; Silman I; Sussman JL
Structure; 1999 Mar; 7(3):297-307. PubMed ID: 10368299
[TBL] [Abstract][Full Text] [Related]
5. Prediction of the binding site of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine in acetylcholinesterase by docking studies with the SYSDOC program.
Pang YP; Kozikowski AP
J Comput Aided Mol Des; 1994 Dec; 8(6):683-93. PubMed ID: 7738604
[TBL] [Abstract][Full Text] [Related]
6. Aromatic amino-acid residues at the active and peripheral anionic sites control the binding of E2020 (Aricept) to cholinesterases.
Saxena A; Fedorko JM; Vinayaka CR; Medhekar R; Radić Z; Taylor P; Lockridge O; Doctor BP
Eur J Biochem; 2003 Nov; 270(22):4447-58. PubMed ID: 14622273
[TBL] [Abstract][Full Text] [Related]
7. Acetylcholinesterase complexed with bivalent ligands related to huperzine a: experimental evidence for species-dependent protein-ligand complementarity.
Wong DM; Greenblatt HM; Dvir H; Carlier PR; Han YF; Pang YP; Silman I; Sussman JL
J Am Chem Soc; 2003 Jan; 125(2):363-73. PubMed ID: 12517147
[TBL] [Abstract][Full Text] [Related]
8. The complex of a bivalent derivative of galanthamine with torpedo acetylcholinesterase displays drastic deformation of the active-site gorge: implications for structure-based drug design.
Greenblatt HM; Guillou C; Guénard D; Argaman A; Botti S; Badet B; Thal C; Silman I; Sussman JL
J Am Chem Soc; 2004 Dec; 126(47):15405-11. PubMed ID: 15563167
[TBL] [Abstract][Full Text] [Related]
9. Complexes of alkylene-linked tacrine dimers with Torpedo californica acetylcholinesterase: Binding of Bis5-tacrine produces a dramatic rearrangement in the active-site gorge.
Rydberg EH; Brumshtein B; Greenblatt HM; Wong DM; Shaya D; Williams LD; Carlier PR; Pang YP; Silman I; Sussman JL
J Med Chem; 2006 Sep; 49(18):5491-500. PubMed ID: 16942022
[TBL] [Abstract][Full Text] [Related]
10. Probing Torpedo californica acetylcholinesterase catalytic gorge with two novel bis-functional galanthamine derivatives.
Bartolucci C; Haller LA; Jordis U; Fels G; Lamba D
J Med Chem; 2010 Jan; 53(2):745-51. PubMed ID: 20025280
[TBL] [Abstract][Full Text] [Related]
11. Kinetic study on the inhibition of acetylcholinesterase by 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine hydrochloride (E2020).
Nochi S; Asakawa N; Sato T
Biol Pharm Bull; 1995 Aug; 18(8):1145-7. PubMed ID: 8535413
[TBL] [Abstract][Full Text] [Related]
12. Molecular dynamics of mouse acetylcholinesterase complexed with huperzine A.
Tara S; Helms V; Straatsma TP; McCammon JA
Biopolymers; 1999 Oct; 50(4):347-59. PubMed ID: 10423544
[TBL] [Abstract][Full Text] [Related]
13. The simulated binding of (+/-)-2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]meth yl] -1H-inden-1-one hydrochloride (E2020) and related inhibitors to free and acylated acetylcholinesterases and corresponding structure-activity analyses.
Inoue A; Kawai T; Wakita M; Iimura Y; Sugimoto H; Kawakami Y
J Med Chem; 1996 Oct; 39(22):4460-70. PubMed ID: 8893840
[TBL] [Abstract][Full Text] [Related]
14. Active-site gorge and buried water molecules in crystal structures of acetylcholinesterase from Torpedo californica.
Koellner G; Kryger G; Millard CB; Silman I; Sussman JL; Steiner T
J Mol Biol; 2000 Feb; 296(2):713-35. PubMed ID: 10669619
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
[TBL] [Abstract][Full Text] [Related]
16. The rationale for E2020 as a potent acetylcholinesterase inhibitor.
Kawakami Y; Inoue A; Kawai T; Wakita M; Sugimoto H; Hopfinger AJ
Bioorg Med Chem; 1996 Sep; 4(9):1429-46. PubMed ID: 8894101
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and acetylcholinesterase inhibitory activity of huperzine A-E2020 combined compound.
Zeng F; Jiang H; Zhai Y; Zhang H; Chen K; Ji R
Bioorg Med Chem Lett; 1999 Dec; 9(23):3279-84. PubMed ID: 10612585
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of tacrine-E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
Shao D; Zou C; Luo C; Tang X; Li Y
Bioorg Med Chem Lett; 2004 Sep; 14(18):4639-42. PubMed ID: 15324879
[TBL] [Abstract][Full Text] [Related]
19. Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
Saxena A; Redman AM; Jiang X; Lockridge O; Doctor BP
Biochemistry; 1997 Dec; 36(48):14642-51. PubMed ID: 9398183
[TBL] [Abstract][Full Text] [Related]
20. Structure of a complex of the potent and specific inhibitor BW284C51 with Torpedo californica acetylcholinesterase.
Felder CE; Harel M; Silman I; Sussman JL
Acta Crystallogr D Biol Crystallogr; 2002 Oct; 58(Pt 10 Pt 2):1765-71. PubMed ID: 12351819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
